- AU$372.63m
- AU$270.51m
- AU$0.19m
Annual income statement for Immutep, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.03 | 7.77 | 0.313 | 0.254 | 0.192 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24.8 | 28.8 | 21.1 | 34.4 | 45.1 |
Operating Profit | -18.8 | -21 | -20.8 | -34.2 | -44.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.3 | -13.5 | -29.9 | -32.2 | -39.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18.3 | -13.5 | -29.9 | -32.2 | -39.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -18.3 | -13.5 | -29.9 | -32.2 | -39.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18.3 | -13.5 | -29.9 | -32.2 | -39.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.054 | -0.033 | -0.053 | -0.04 | -0.044 |